# Arq, Inc.: financial statements, quarterly ARQ · Nasdaq · CIK 1515156 · [Materials](/sectors/materials.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/arq.md) · [Financials](/companies/arq/financials.md) · [Filings](/companies/arq/filings.md) · [Insiders](/companies/arq/insiders.md) Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/arq/financials.md?period=annual). ## Income statement | Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [29.8](/filings/0001515156-24-000174.md) | [28.1 d](/filings/0001515156-25-000014.md) | [21.7](/filings/0001515156-25-000058.md) | [25.4](/filings/0001515156-25-000114.md) | [34.8](/filings/0001515156-25-000138.md) | [27.0 d](/filings/0001515156-26-000021.md) | [27.2](/filings/0001515156-26-000062.md) | [28.6](/filings/0001515156-26-000114.md) | [35.1](/filings/0001515156-25-000138.md) | [29.4 d](/filings/0001515156-26-000021.md) | [29.1](/filings/0001515156-26-000062.md) | [29.9](/filings/0001515156-26-000114.md) | | Cost of revenue | $m | [20.7](/filings/0001515156-24-000174.md) | [14.1 d](/filings/0001515156-25-000014.md) | [13.7](/filings/0001515156-25-000058.md) | [17.2](/filings/0001515156-25-000114.md) | [21.3](/filings/0001515156-25-000138.md) | [17.2 d](/filings/0001515156-26-000021.md) | [17.3](/filings/0001515156-26-000062.md) | [19.1](/filings/0001515156-26-000114.md) | [25.0](/filings/0001515156-25-000138.md) | [25.4 d](/filings/0001515156-26-000021.md) | [19.1](/filings/0001515156-26-000062.md) | [18.4](/filings/0001515156-26-000114.md) | | Gross profit | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Research and development | $m | [0.6](/filings/0001515156-24-000174.md) | [1.2 d](/filings/0001515156-25-000014.md) | [1.6](/filings/0001515156-25-000058.md) | [0.9](/filings/0001515156-25-000114.md) | [0.8](/filings/0001515156-25-000138.md) | [0.7 d](/filings/0001515156-26-000021.md) | [0.9](/filings/0001515156-26-000062.md) | [2.7](/filings/0001515156-26-000114.md) | [2.6](/filings/0001515156-25-000138.md) | [1.2 d](/filings/0001515156-26-000021.md) | [1.0](/filings/0001515156-26-000062.md) | [1.0](/filings/0001515156-26-000114.md) | | Selling, general and administrative | $m | [8.3](/filings/0001515156-24-000174.md) | [6.5 d](/filings/0001515156-25-000014.md) | [7.7](/filings/0001515156-25-000058.md) | [7.0](/filings/0001515156-25-000114.md) | [8.1](/filings/0001515156-25-000138.md) | [6.0 d](/filings/0001515156-26-000021.md) | [6.1](/filings/0001515156-26-000062.md) | [5.9](/filings/0001515156-26-000114.md) | [4.6](/filings/0001515156-25-000138.md) | [6.0 d](/filings/0001515156-26-000021.md) | [7.4](/filings/0001515156-26-000062.md) | [6.8](/filings/0001515156-26-000114.md) | | Operating income | $m | [(2.5)](/filings/0001515156-24-000174.md) | [3.1 d](/filings/0001515156-25-000014.md) | [(3.0)](/filings/0001515156-25-000058.md) | [(1.4)](/filings/0001515156-25-000114.md) | [2.0](/filings/0001515156-25-000138.md) | [0.4 d](/filings/0001515156-26-000021.md) | [0.7](/filings/0001515156-26-000062.md) | [(1.8)](/filings/0001515156-26-000114.md) | [(0.8)](/filings/0001515156-25-000138.md) | [(51.2) d](/filings/0001515156-26-000021.md) | [(1.0)](/filings/0001515156-26-000062.md) | [(0.1)](/filings/0001515156-26-000114.md) | | Interest expense | $m | [0.8](/filings/0001515156-23-000133.md) | [0.9 d](/filings/0001515156-24-000036.md) | [0.8](/filings/0001515156-24-000095.md) | [0.8](/filings/0001515156-25-000114.md) | [0.8](/filings/0001515156-25-000138.md) | [0.8 d](/filings/0001515156-26-000021.md) | [0.7](/filings/0001515156-26-000062.md) | [0.6](/filings/0001515156-26-000114.md) | [0.6](/filings/0001515156-25-000138.md) | [0.5 d](/filings/0001515156-26-000021.md) | [0.7](/filings/0001515156-26-000062.md) | [0.7](/filings/0001515156-26-000114.md) | | Income tax | $m | [0.0](/filings/0001515156-24-000174.md) | [0.2 d](/filings/0001515156-25-000014.md) | [0.0](/filings/0001515156-25-000058.md) | [0.0](/filings/0001515156-25-000114.md) | [0.0](/filings/0001515156-25-000138.md) | [(0.2) d](/filings/0001515156-26-000021.md) | [0.0](/filings/0001515156-26-000062.md) | [0.0](/filings/0001515156-26-000114.md) | [0.0](/filings/0001515156-25-000138.md) | [0.0 d](/filings/0001515156-26-000062.md) | [0.0](/filings/0001515156-26-000062.md) | [0.0](/filings/0001515156-26-000114.md) | | Net income | $m | [(2.2)](/filings/0001515156-24-000174.md) | [3.3 d](/filings/0001515156-25-000014.md) | [(3.4)](/filings/0001515156-25-000138.md) | [(2.0)](/filings/0001515156-25-000138.md) | [1.6](/filings/0001515156-25-000138.md) | [(1.3) d](/filings/0001515156-26-000021.md) | [(0.0)](/filings/0001515156-26-000114.md) | [(2.4)](/filings/0001515156-26-000114.md) | [(0.7)](/filings/0001515156-25-000138.md) | [(50.0) d](/filings/0001515156-26-000021.md) | [(1.1)](/filings/0001515156-26-000114.md) | [(0.7)](/filings/0001515156-26-000114.md) | | Diluted EPS | $ per share | [(0.07)](/filings/0001515156-24-000174.md) | not reported | [(0.09)](/filings/0001515156-25-000058.md) | [(0.06)](/filings/0001515156-25-000114.md) | [0.04](/filings/0001515156-25-000138.md) | not reported | [0.00](/filings/0001515156-26-000062.md) | [(0.06)](/filings/0001515156-26-000114.md) | [(0.02)](/filings/0001515156-25-000138.md) | not reported | [(0.02)](/filings/0001515156-26-000062.md) | [(0.02)](/filings/0001515156-26-000114.md) | | Basic EPS | $ per share | [(0.07)](/filings/0001515156-24-000174.md) | not reported | [(0.09)](/filings/0001515156-25-000058.md) | [(0.06)](/filings/0001515156-25-000114.md) | [0.04](/filings/0001515156-25-000138.md) | not reported | [0.00](/filings/0001515156-26-000062.md) | [(0.06)](/filings/0001515156-26-000114.md) | [(0.02)](/filings/0001515156-25-000138.md) | not reported | [(0.02)](/filings/0001515156-26-000062.md) | [(0.02)](/filings/0001515156-26-000114.md) | - Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax - Cost of revenue: us-gaap:CostOfGoodsAndServicesSold - Gross profit: not reported - Research and development: us-gaap:ResearchAndDevelopmentExpense - Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense - Operating income: us-gaap:OperatingIncomeLoss - Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating - Income tax: us-gaap:IncomeTaxExpenseBenefit - Net income: us-gaap:NetIncomeLoss - Diluted EPS: us-gaap:EarningsPerShareDiluted - Basic EPS: us-gaap:EarningsPerShareBasic ## Balance sheet | Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Cash and equivalents | $m | [52.5](/filings/0001515156-23-000133.md) | [45.4](/filings/0001515156-25-000014.md) | [35.2](/filings/0001515156-24-000095.md) | [28.5](/filings/0001515156-24-000144.md) | [48.7](/filings/0001515156-24-000174.md) | [13.5](/filings/0001515156-26-000021.md) | [6.3](/filings/0001515156-25-000058.md) | [7.0](/filings/0001515156-25-000114.md) | [7.0](/filings/0001515156-25-000138.md) | [6.6](/filings/0001515156-26-000114.md) | [4.7](/filings/0001515156-26-000062.md) | [0.9](/filings/0001515156-26-000114.md) | | Current assets | $m | [91.5](/filings/0001515156-23-000133.md) | [86.5](/filings/0001515156-25-000014.md) | [72.0](/filings/0001515156-24-000095.md) | [71.2](/filings/0001515156-24-000144.md) | [87.3](/filings/0001515156-24-000174.md) | [52.4](/filings/0001515156-26-000021.md) | [48.2](/filings/0001515156-25-000058.md) | [50.7](/filings/0001515156-25-000114.md) | [43.9](/filings/0001515156-25-000138.md) | [43.9](/filings/0001515156-26-000114.md) | [46.1](/filings/0001515156-26-000062.md) | [47.2](/filings/0001515156-26-000114.md) | | Total assets | $m | [231](/filings/0001515156-23-000133.md) | [236](/filings/0001515156-25-000014.md) | [230](/filings/0001515156-24-000095.md) | [249](/filings/0001515156-24-000144.md) | [280](/filings/0001515156-24-000174.md) | [284](/filings/0001515156-26-000021.md) | [284](/filings/0001515156-25-000058.md) | [285](/filings/0001515156-25-000114.md) | [278](/filings/0001515156-25-000138.md) | [231](/filings/0001515156-26-000114.md) | [232](/filings/0001515156-26-000062.md) | [233](/filings/0001515156-26-000114.md) | | Current liabilities | $m | [22.0](/filings/0001515156-23-000133.md) | [23.0](/filings/0001515156-25-000014.md) | [22.0](/filings/0001515156-24-000095.md) | [26.6](/filings/0001515156-24-000144.md) | [30.2](/filings/0001515156-24-000174.md) | [44.7](/filings/0001515156-26-000021.md) | [43.0](/filings/0001515156-25-000058.md) | [46.2](/filings/0001515156-25-000114.md) | [39.8](/filings/0001515156-25-000138.md) | [42.3](/filings/0001515156-26-000114.md) | [45.1](/filings/0001515156-26-000062.md) | [46.0](/filings/0001515156-26-000114.md) | | Total liabilities | $m | [56.3](/filings/0001515156-23-000133.md) | [57.1](/filings/0001515156-25-000014.md) | [54.6](/filings/0001515156-24-000095.md) | [59.0](/filings/0001515156-24-000144.md) | [61.8](/filings/0001515156-24-000174.md) | [67.1](/filings/0001515156-26-000021.md) | [65.5](/filings/0001515156-25-000058.md) | [67.8](/filings/0001515156-25-000114.md) | [60.8](/filings/0001515156-25-000138.md) | [62.6](/filings/0001515156-26-000114.md) | [64.3](/filings/0001515156-26-000062.md) | [64.8](/filings/0001515156-26-000114.md) | | Long-term debt | $m | [19.2](/filings/0001515156-23-000133.md) | [18.3](/filings/0001515156-25-000014.md) | [18.1](/filings/0001515156-24-000095.md) | [18.0](/filings/0001515156-24-000144.md) | [17.6](/filings/0001515156-24-000174.md) | [9.4](/filings/0001515156-26-000021.md) | [9.1](/filings/0001515156-25-000058.md) | [8.7](/filings/0001515156-25-000114.md) | [8.8](/filings/0001515156-25-000138.md) | [8.5](/filings/0001515156-26-000114.md) | [8.2](/filings/0001515156-26-000062.md) | [8.2](/filings/0001515156-26-000114.md) | | Current portion of debt | $m | [2.0](/filings/0001515156-23-000133.md) | [2.7](/filings/0001515156-25-000014.md) | [2.5](/filings/0001515156-24-000095.md) | [2.4](/filings/0001515156-24-000144.md) | [2.3](/filings/0001515156-24-000174.md) | [15.5](/filings/0001515156-26-000021.md) | [17.8](/filings/0001515156-25-000058.md) | [20.0](/filings/0001515156-25-000114.md) | [17.1](/filings/0001515156-25-000138.md) | [20.0](/filings/0001515156-26-000114.md) | [22.0](/filings/0001515156-26-000062.md) | [22.5](/filings/0001515156-26-000114.md) | | Short-term borrowings | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Shareholders' equity | $m | [174](/filings/0001515156-24-000174.md) | [178](/filings/0001515156-26-000021.md) | [175](/filings/0001515156-25-000138.md) | [190](/filings/0001515156-25-000138.md) | [218](/filings/0001515156-25-000138.md) | [219](/filings/0001515156-26-000114.md) | [219](/filings/0001515156-26-000114.md) | [218](/filings/0001515156-26-000114.md) | [217](/filings/0001515156-25-000138.md) | [168](/filings/0001515156-26-000114.md) | [168](/filings/0001515156-26-000114.md) | [168](/filings/0001515156-26-000114.md) | - Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue - Current assets: us-gaap:AssetsCurrent - Total assets: us-gaap:Assets - Current liabilities: us-gaap:LiabilitiesCurrent - Total liabilities: us-gaap:Liabilities - Long-term debt: us-gaap:LongTermDebtNoncurrent - Current portion of debt: us-gaap:LongTermDebtCurrent - Short-term borrowings: not reported - Shareholders' equity: us-gaap:StockholdersEquity ## Cash flow | Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Operating cash flow | $m | [0.0 d](/filings/0001515156-24-000174.md) | [4.5 d](/filings/0001515156-25-000014.md) | [0.5](/filings/0001515156-25-000058.md) | [(3.0) d](/filings/0001515156-25-000114.md) | [7.7 d](/filings/0001515156-25-000138.md) | [5.2 d](/filings/0001515156-26-000021.md) | [(5.8)](/filings/0001515156-26-000062.md) | [0.5 d](/filings/0001515156-26-000114.md) | [5.3 d](/filings/0001515156-25-000138.md) | [(2.8) d](/filings/0001515156-26-000021.md) | [0.1](/filings/0001515156-26-000062.md) | [(2.7) d](/filings/0001515156-26-000114.md) | | Capital expenditure | $m | [6.6 d](/filings/0001515156-24-000174.md) | [10.5 d](/filings/0001515156-25-000014.md) | [9.6](/filings/0001515156-25-000058.md) | [19.2 d](/filings/0001515156-25-000114.md) | [13.4 d](/filings/0001515156-25-000138.md) | [43.0 d](/filings/0001515156-26-000021.md) | [3.7](/filings/0001515156-26-000062.md) | [1.9 d](/filings/0001515156-26-000114.md) | [2.2 d](/filings/0001515156-25-000138.md) | [0.8 d](/filings/0001515156-26-000021.md) | [0.7](/filings/0001515156-26-000062.md) | [1.2 d](/filings/0001515156-26-000114.md) | | Dividends paid | $m | [0.0 d](/filings/0001515156-23-000133.md) | [0.0 d](/filings/0001515156-24-000036.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | - Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities - Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets - Dividends paid: us-gaap:PaymentsOfDividends - Share repurchases: not reported ## Shares | Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Diluted shares (weighted) | millions of shares | [18.5](/filings/0001515156-23-000133.md) | [23.8](/filings/0001515156-24-000095.md) | [27.4](/filings/0001515156-24-000144.md) | [31.8](/filings/0001515156-24-000174.md) | [37.1](/filings/0001515156-25-000058.md) | [34.4](/filings/0001515156-25-000114.md) | [37.4](/filings/0001515156-25-000138.md) | [42.5](/filings/0001515156-26-000062.md) | [41.5](/filings/0001515156-26-000114.md) | [41.6](/filings/0001515156-25-000138.md) | [41.7](/filings/0001515156-26-000062.md) | [42.1](/filings/0001515156-26-000114.md) | - Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding Shares outstanding: 43,668,483 at 2026-08-06, from the cover of the [10-Q filed 2026-08-10](/filings/0001515156-26-000114.md) (dei:EntityCommonStockSharesOutstanding). Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:41 ET. No prices; not investment advice.